AKESOgen Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- AKESOgen's estimated annual revenue is currently $6.2M per year.
- AKESOgen's estimated revenue per employee is $155,000
- AKESOgen has 40 Employees.
- AKESOgen grew their employee count by 25% last year.
- AKESOgen currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Women In Bio - ...||$12.7M||82||44%||N/A|
What Is AKESOgen?
AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA. AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market. AKESOgen establishes and validates biomarkers in the Clinical Trials arena. AKESOgen has expertise in Biobanking.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Mark Bouzyk||Co-founder & Chief Scientific Officer||Email Available|
|Maria Mikkelson||Vp, Information Technology||Email Available|
|Lauren McGoldrick||Vice President Client Services||Email Available|
|Ricky Lowe||Manager, Bioinformatics And Data Management||Email Available|
|Rachel Crossen||Senior Director, Business Development, Genomic Services||Email Available|
|Krishna Amin||Clinical Assay Development And Quality Manager||Email Available|
|Laura Alarcon||Assistant Project Manager||Email Available|
|Robert Boisjoli||Chief Executive Officer /founder||Email Available|
|Gabriela Oprea-llies||Laboratory Medical Director|
|Barbara Glazer||Director, Compliance & Clinical Trial Project Management.||Email Available|
NEW YORK, Feb. 13, 2019 /PRNewswire/ -- RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney ...
LONDON (Alliance News) - Renalytix AI PLC on Wednesday said it has entered into a partnership agreement with laboratory facility provider ...
“AKESOgen brings a state-of-the-art CLIA-certified and CAP-accredited laboratory facility that enables RenalytixAI to immediately scale ...